Future Oncology
Volume 19, 2023 - Issue 12
Open access
1,326
Views
0
CrossRef citations to date
0
Altmetric
Short Communication
Darolutamide in Spanish patients with nonmetastatic castration-resistant prostate cancer: ARAMIS subgroup analysis
Joan Carles1 Vall d’Hebron Institute of Oncology, Hospital Universitari Vall d’Hebron,
Barcelona, SpainCorrespondence[email protected]
https://orcid.org/0000-0002-9983-5934View further author information
Rafael A Medina-Lopez2 Urology Department,Vírgen del Rocío University Hospital,
Seville, Spain
https://orcid.org/0000-0002-4514-4329View further author information
Javier Puente3 Medical Oncology Department, Hospital Clínico San Carlos,Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), CIBERONC,
Madrid, Spain
https://orcid.org/0000-0002-6910-1331View further author information
Álvaro Gómez-Ferrer4 Instituto Valenciano de Oncologia,
Valencia, Spain
https://orcid.org/0000-0003-0511-7569View further author information
Javier Casas Nebra5 Hospital Universitario Lucus Augusti, Lugo, Spain
https://orcid.org/0000-0002-9346-0799View further author information
María Isabel Sáez Medina6 UGCI of Medical Oncology, Hospitales Regional & Universitario Virgen de la Victoria, IBIMA, UMA,
Malaga, Spain
https://orcid.org/0000-0002-4885-7789View further author information
Maria J Ribal7 Uro-Oncology Unit, Hospital Clinic, University of Barcelona,
Barcelona, Spain
https://orcid.org/0000-0001-8142-5382View further author information
Alfredo Rodríguez Antolín8 Hospital Universitario 12 de Octubre,
Madrid, Spain
https://orcid.org/0000-0002-7841-708XView further author information
José Luís Álvarez-Ossorio9 Department of Urology,Puerta del Mar University Hospital,
Cádiz, Spain
https://orcid.org/0000-0001-9956-8453View further author information
José Francisco Suárez Novo10 Hospital Universitari de Bellvitge, l’Hospitalet de Llobregat, Spain
https://orcid.org/0000-0002-0171-0413View further author information
Cristina Moretones Agut11 Bayer Hispania, SL, Sant Joan Despí, SpainView further author information
, Shankar Srinivasan12 Bayer HealthCare,
Whippany,
NJ07981,
USA
https://orcid.org/0000-0002-5843-7008View further author information
Jorge Ortiz12 Bayer HealthCare,
Whippany,
NJ07981,
USAView further author information
& Karim Fizazi13 Institut Gustave Roussy, University of Paris-Saclay,
Villejuif,
France
https://orcid.org/0000-0002-6068-9474View further author information
Pages 819-828
|
Received 14 Nov 2022, Accepted 18 Apr 2023, Published online: 24 May 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.